FDA Gives The Okay For Abbott’s New Minimally Invasive Pacemaker

Argentina Noticias Noticias

FDA Gives The Okay For Abbott’s New Minimally Invasive Pacemaker
Argentina Últimas Noticias,Argentina Titulares
  • 📰 Forbes
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 53%

On Wednesday, medtech giant Abbott announced that its new leadless pacemaker system, Aveir DR, has been approved by the FDA. This is the first time the FDA has given a thumbs up to a device of this type for two different chambers of the heart.

in March 2022. Both of these products, however, only work in a single chamber of the heart. About 80% of the patients that require a pacemaker need shocks in two cardiac chambers in order to keep the desired heart rhythm.

Abbott engineers solved this with a proprietary system the company markets as “i2i.” The communication system works by transmitting high frequency electric pulses that take advantage of the electric conductivity of blood to deliver the signal. “So with this incredibly efficient, conducted telemetry, we can get reasonable battery longevity ease, despite the fact that the devices are tiny, and they're communicating with each other within every heartbeat,” explains Ganz.

“What’s amazing about this is the ability for the two devices, the one in the top and bottom chambers, to communicate with each other,” says Vivek Reddy, an author of the study and electrophysiologist at Mt. Sinai whose lab receives grant support from Abbott. Another aspect of the clinical study he highlights is that there was only one patient who experienced a serious complication in implanting the device out of the 295 patients.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Forbes /  🏆 394. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Tyler James Williams isn't concerned about Abbott Elementary delay amid strikeTyler James Williams isn't concerned about Abbott Elementary delay amid strike'We stand behind them a hundred percent, completely,' Williams said in support of writers on the picket line
Leer más »

US FDA declines to approve Amneal's Parkinson's drug over safety concernsUS FDA declines to approve Amneal's Parkinson's drug over safety concernsThe U.S. Food and Drug Administration (FDA) has declined to approve Amneal Pharmaceuticals' drug designed to help control symptoms in Parkinson's disease patients for a longer duration, citing inadequate safety data.
Leer más »

'More To The Story': Younger Revival Chances Responded By Star After Ending 2 Years Ago'More To The Story': Younger Revival Chances Responded By Star After Ending 2 Years AgoYounger star Nico Tortorella gives an optimistic revival update, saying there’s more story to tell after the show’s open-ended conclusion.
Leer más »

Biden's Tour Poster Gives Major Coachella Vibes And We Can't Stop LaughingBiden's Tour Poster Gives Major Coachella Vibes And We Can't Stop LaughingBiden's 'Investing In America' tour features opening acts like VP Harris and Janet Yellen.
Leer más »

Rosie O’Donnell Gives Madonna Update, Says She’s ‘Strong in General’Rosie O’Donnell Gives Madonna Update, Says She’s ‘Strong in General’The comedian took to Instagram to share a throwback photo of the duo starring in A League of Their Own.
Leer más »



Render Time: 2025-04-01 23:57:05